Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma.
Paiella S, Malleo G, Simoni N, Micera R, Guariglia S, Cavedon C, Marchegiani G, Esposito A, Landoni L, Casetti L, Tuveri M, Milella M, Secchettin E, Manzini G, Bovo C, De Pastena M, Fontana M, Salvia R, Mazzarotto R, Bassi C. Paiella S, et al. Among authors: simoni n. BMC Cancer. 2021 Feb 16;21(1):165. doi: 10.1186/s12885-021-07877-7. BMC Cancer. 2021. PMID: 33593311 Free PMC article.
Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1).
Arcelli A, Guido A, Buwenge M, Simoni N, Mazzarotto R, Macchia G, Deodato F, Cilla S, Bonomo P, Scotti V, Belgioia L, Tolento G, Cellini F, Grassi E, DI Marco M, Casadei R, Morganti AG, Cammelli S. Arcelli A, et al. Among authors: simoni n. Anticancer Res. 2020 Jan;40(1):465-472. doi: 10.21873/anticanres.13975. Anticancer Res. 2020. PMID: 31892602
Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB technique, MRgRT, Particle Therapy, Immunotherapy and Clinical Guidelines.
Cellini F, Arcelli A, Simoni N, Caravatta L, Buwenge M, Calabrese A, Brunetti O, Genovesi D, Mazzarotto R, Deodato F, Mattiucci GC, Silvestris N, Valentini V, Morganti AG. Cellini F, et al. Among authors: simoni n. Cancers (Basel). 2020 Jun 29;12(7):1729. doi: 10.3390/cancers12071729. Cancers (Basel). 2020. PMID: 32610592 Free PMC article. Review.
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma.
Simoni N, Micera R, Paiella S, Guariglia S, Zivelonghi E, Malleo G, Rossi G, Addari L, Giuliani T, Pollini T, Cavedon C, Salvia R, Milella M, Bassi C, Mazzarotto R. Simoni N, et al. Clin Oncol (R Coll Radiol). 2021 Jan;33(1):e31-e38. doi: 10.1016/j.clon.2020.06.019. Epub 2020 Jul 15. Clin Oncol (R Coll Radiol). 2021. PMID: 32682686
Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1).
Arcelli A, Buwenge M, Macchia G, Bertini F, Guido A, Deodato F, Cilla S, Scotti V, Rosetto ME, Djan I, Parisi S, Mattiucci GC, Cellini F, Fiore M, Bonomo P, Belgioia L, Niespolo RM, Gabriele P, Di Marco M, Simoni N, Mazzarotto R, Morganti AG; AIRO (Italian Association of Radiation Oncology and Clinical Oncology) Gastrointestinal Study Group. Arcelli A, et al. Among authors: simoni n. Cancer Med. 2020 Nov;9(21):7879-7887. doi: 10.1002/cam4.3330. Epub 2020 Sep 10. Cancer Med. 2020. PMID: 32910549 Free PMC article.
Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy.
La Mendola R, Bencivenga M, Torroni L, Alberti L, Sacco M, Casella F, Ridolfi C, Simoni N, Micera R, Pavarana M, Verlato G, Giacopuzzi S. La Mendola R, et al. Among authors: simoni n. Ann Surg Oncol. 2021 Jun;28(6):3034-3043. doi: 10.1245/s10434-020-09219-6. Epub 2020 Oct 19. Ann Surg Oncol. 2021. PMID: 33078313 Free PMC article.
18F-FDG PET/CT Metrics Are Correlated to the Pathological Response in Esophageal Cancer Patients Treated With Induction Chemotherapy Followed by Neoadjuvant Chemo-Radiotherapy.
Simoni N, Rossi G, Benetti G, Zuffante M, Micera R, Pavarana M, Guariglia S, Zivelonghi E, Mengardo V, Weindelmayer J, Giacopuzzi S, de Manzoni G, Cavedon C, Mazzarotto R. Simoni N, et al. Front Oncol. 2020 Nov 27;10:599907. doi: 10.3389/fonc.2020.599907. eCollection 2020. Front Oncol. 2020. PMID: 33330097 Free PMC article.
22 results